Effect of Acupuncture on the Gait Disturbance and Hemodynamic Changes in the Prefrontal Cortex - Trial NCT06346275
Access comprehensive clinical trial information for NCT06346275 through Pure Global AI's free database. This phase not specified trial is sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University and is currently Not yet recruiting. The study focuses on Alzheimer Disease. Target enrollment is 108 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The Third Affiliated hospital of Zhejiang Chinese Medical University
Timeline & Enrollment
N/A
Jul 01, 2024
Apr 01, 2025
Primary Outcome
Three-dimensional gait analysis,Cerebral hemodynamics
Summary
Background: Alzheimer's disease (AD) is characterized by cognitive impairment and behavioral
 impairment, and increasing attention is paid in the gait of AD patients. The aim of this
 randomized controlled trial (RCT) is to explore the effect of acupuncture on the cognitive
 function, gait performance, and hemodynamic changes in the prefrontal cortices.
 
 Methods: In this RCT, a total of 108 AD patients will be randomly assigned into acupuncture
 group or control group for 8 weeks. The primary outcome will be Three-dimensional gait
 analysis and cerebral hemodynamics using functional near-infrared spectroscopy (fNIRS).
 Secondary outcomes include Mini-Mental State Examination (MMSE), Montreal Cognitive
 Assessment (MoCA), and Barthel Index (BI).
 
 Discussion: This trial is expected to explore the effect of acupuncture on cognitive
 function, gait performance, and hemodynamic changes in the prefrontal cortices for AD
 patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06346275
Non-Device Trial

